Skip to content
City PM
  • Germany
  • France
  • Europe
  • Markets
  • Business
  • Opinion
  • Germany
  • France
  • Europe
  • Markets
  • Business
  • Opinion
Sunday 12 December 2021 2:46 pm  |  Updated:  Sunday 12 December 2021 3:10 pm

Omicron “mild” compared to delta, South African doctors say

By: Farah Ghouri

Add as a preferred source on Google
UK Covid Face Mask Rules Tightened Over Omicron Variant Fear
Confusion over Covid rules will only threaten the UK’s economic recovery

Omicron is a mild disease, said Dr Angelique Coetzee of the South African Medical Association in an LBC interview today.

Coetzee, the first South African doctor to alert authorities about patients with the omicron variant, insisted that: “There’s no reason why you can’t trust us when we say to you [Omicron is] a mild disease.”

She acknowledged that there would be some sick patients, but said “it will be the minority”.

Patients “recover within about five days whether you are a child, 80 years of age, whether you’ve been vaccinated or not,” Coetzee explained.

Her comments come as the UK re-enters pandemic restrictions following a wave of Omicron cases. The first people to be hospitalised with Omicron infections have also been reported today by the BBC, according to education secretary Nadhim Zahawi, who has warned that the new Covid-19 variant now accounts for a third of cases in London.

But Coetzee said, based on the experience in South Africa over the last four weeks, “there’s no need to hospitalise any of these mild cases. There’s really no need.”

“The severity of the disease is not delta. It is mild disease,” she said of the new Covid-19 variant, which was first detected by researchers in Southern Africa at the end of November.

“Our ICUs are not full. Our public sector hospitals have seen an increase but they don’t have a lot of beds.”

South Africa’s National Institute for Communicable Diseases confirmed that only around 30 per cent of people hospitalised with Covid in recent weeks have been seriously ill – less than half the rate compared to the first weeks of previous waves of the pandemic.

Read more

Alkermes Presents Detailed Positive Results From Vibrance-2 Phase 2 Study of Alixorexton in Adults With Narcolepsy Type 2 at SLEEP 2026

Share this article

  • Facebook
  • X
  • LinkedIn
  • WhatsApp
  • Email

Similarly tagged content:

Sections

  • News

Categories

  • Business

Related Topics

  • Coronavirus

Trending Articles

  • Government intervenes on foreign takeover bids for UK defence firms

  • Wayve hands London private market ‘major boost’ with $85m share sale

  • Mr John Wrottesley Appointed as New General Manager of International Cable Protection Committee (ICPC)

  • Nothing fails to file accounts months after dissolution threat

  • NBA Europe bids fall short of $500m mark for some city franchises

More from City PM

  • Alkermes Presents Detailed Positive Results From Vibrance-2 Phase 2 Study of Alixorexton in Adults With Narcolepsy Type 2 at SLEEP 2026

    Business Wire
  • Silence Therapeutics Highlights Follow-Up Data at EHA 2026 Demonstrating Durable Efficacy and Potential Best-in-Class Profile for Divesiran in Polycythemia Vera

    Business Wire
  • Alkermes to Present New Data on Alixorexton and LUMRYZ® (sodium oxybate) at SLEEP 2026, Highlighting Breadth of Sleep Medicine Research

    Business Wire
  • Anocca has Dosed First Patients with Precision TCR-T Cell Therapy Targeting Mutant KRAS in Pancreatic Cancer

    Business Wire
  • IMU Biosciences announces oversubscribed financing round, bringing its Series A to over $53M as it accelerates its work to decode the immune system with unprecedented resolution and scale, to transform how we understand, diagnose and treat disease

    Business Wire
  • cTAP Announces Novel Prognostic Score Developed for Duchenne Muscular Dystrophy Patients Offers Improved Prediction of Loss of Ambulation

    Business Wire
  • Two T20 franchises to merge as external investment nears

    Sport Business
    Business professionals discussing strategies in a modern office setting with laptops and documents on a conference table
  • Investec shares rise amid takeover speculation

    Investing
    Investec has selected the four winners of its Beyond Business programme

City PM — European politics, business and analysis.

Europe

  • Germany
  • France
  • Europe
  • UK & Ireland

Topics

  • Business
  • Markets
  • AI
  • Technology
  • Opinion
  • Energy

More

  • Politics
  • Economics
  • Fintech
  • Legal
  • Sport
  • Life

Company

  • About City PM
  • Editorial Policy
  • Corrections
  • Contact
  • Terms of Use
  • Privacy Policy
  • Cookie Policy
© 2026 City PM · Published by CityPM Media, Bahnhofstrasse 65, 8001 Zürich, Switzerland
About · Editorial Policy · Corrections · Contact · Privacy